Markovits, Stock & DeMarco, LLC, a law firm experienced in data breach and Meta pixel class action litigation, is investigating claims on behalf of victims of a data breach involving data entrusted to Medtronic Minimed, Inc. and Medtronic Distribution Corp. (aka Medtronic Diabetes) through their InPen™ Diabetes Management iOS and Android mobile applications (the “InPen App”). If you received a data breach notification from Medtronic Diabetes, please contact us as soon as possible to understand your legal rights in response to the data breach.
Medtronic Diabetes is a medical device manufacturing company headquartered in Minneapolis, MN, which sells a variety of insulin delivery systems to patients suffering from diabetes, with an annual revenue of $570 million. It is a subsidiary of Medtronic in Ireland, with global revenue of $31.5 billion. 
On April 14, 2023, Medtronic Diabetes reported that it had discovered that several Google Services tracking and authentication technologies used by the company had disclosed certain information about users through the company’s InPen App to Google without the users’ permission, through February 13, 2023. Medtronic Diabetes revealed the InPen App had used Google Analytics for Firebase (“Google Analytics”), Crashlytics for Firebase (“Crashlytics”) and Firebase Authentication (collectively “Google Services”), which had gathered and sent personal identifying information and protected health information to Google.
What Data is Involved in the Medtronic Diabetes Data Breach?
- E-mail address
- IP Address
- Phone number
- InPen App user name and password
- Certain unique identifiers tied to your InPen account or mobile device 
What Should I do if I Received Notification of the Data Breach from Medtronic Diabetes?
If you would like to have a free, confidential consultation with an attorney to learn more about your rights and potential legal remedies related to the Medtronic Diabetes data security breach, please contact Markovits, Stock & DeMarco attorney Terry Coates at (513) 651-3700, email us at [email protected], or submit a Case Evaluation request through the form below.